糖尿病脑梗塞患者血浆CD62P测定及意义

来源 :上海第二医科大学学报 | 被引量 : 0次 | 上传用户:wa0001
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的揭示血浆血小板膜蛋白CD6 2P对脑梗塞患者血管病变的诊断和预后价值。 方法流式细胞术观察糖尿病与非糖尿病脑梗塞患者CD6 2P的阳性表达率 ,并与健康人作对照。 结果脑梗塞组CD6 2P的阳性表达率高于对照组 (P <0 .0 1) ,且合并有糖尿病组显著高于非糖尿病组 (P <0 .0 1) ;脑梗塞组血小板计数与对照组比较无显著差异。 结论脑梗塞时血小板活化程度明显增高 ,而糖尿病则加剧了这一病理过程的发生。 Objective To reveal the value of plasma platelet membrane protein CD6 2P in the diagnosis and prognosis of vascular lesions in patients with cerebral infarction. Methods The positive rate of CD6 2P expression in diabetic and non-diabetic cerebral infarction patients was observed by flow cytometry and was compared with healthy controls. Results The positive rate of CD6 2P in cerebral infarction group was significantly higher than that in control group (P <0.01), and the level of CD6 2P in cerebral infarction group was significantly higher than that in non-diabetic group (P <0.01) No significant difference between groups. Conclusion The activation of platelet in cerebral infarction is obviously increased, while diabetes aggravates the occurrence of this pathological process.
其他文献